EV Biologics Inc (YECO)
0.6221
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
EV Biologics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 6.033 |
| April 30, 2024 | 6.033 |
| April 29, 2024 | 6.033 |
| April 26, 2024 | 6.033 |
| April 25, 2024 | 5.839 |
| April 24, 2024 | 5.839 |
| April 23, 2024 | 5.839 |
| April 22, 2024 | 5.839 |
| April 19, 2024 | 5.839 |
| April 18, 2024 | 5.839 |
| April 17, 2024 | 5.839 |
| April 16, 2024 | 5.839 |
| April 15, 2024 | 5.839 |
| April 12, 2024 | 5.839 |
| April 11, 2024 | 5.839 |
| April 10, 2024 | 5.839 |
| April 09, 2024 | 5.839 |
| April 08, 2024 | 5.839 |
| April 05, 2024 | 5.839 |
| April 04, 2024 | 5.839 |
| April 03, 2024 | 5.460 |
| April 02, 2024 | 5.460 |
| April 01, 2024 | 5.460 |
| March 28, 2024 | 6.827 |
| March 27, 2024 | 6.827 |
| Date | Value |
|---|---|
| March 26, 2024 | 6.827 |
| March 25, 2024 | 6.827 |
| March 22, 2024 | 6.827 |
| March 21, 2024 | 6.827 |
| March 20, 2024 | 6.827 |
| March 19, 2024 | 6.827 |
| March 18, 2024 | 6.818 |
| March 15, 2024 | 6.818 |
| March 14, 2024 | 6.818 |
| March 13, 2024 | 6.818 |
| March 12, 2024 | 9.212 |
| March 11, 2024 | 9.212 |
| March 08, 2024 | 9.212 |
| March 07, 2024 | 9.585 |
| March 06, 2024 | 9.585 |
| March 05, 2024 | 9.585 |
| March 04, 2024 | 6.818 |
| March 01, 2024 | 6.818 |
| February 29, 2024 | 6.818 |
| February 28, 2024 | 6.818 |
| February 27, 2024 | 6.818 |
| February 26, 2024 | 6.818 |
| February 23, 2024 | 6.818 |
| February 22, 2024 | 6.818 |
| February 21, 2024 | 6.818 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2638
Minimum
Mar 04 2020
58.19
Maximum
Jan 22 2021
12.47
Average
8.049
Median
Mar 22 2023
Price to Book Value Benchmarks
| CEL-SCI Corp | 6.209 |
| AIM ImmunoTech Inc | 2.065 |
| IGC Pharma Inc | 3.590 |
| NovaBay Pharmaceuticals Inc | 1.982 |
| Protalix BioTherapeutics Inc | 2.535 |
Price to Book Value Related Metrics
| Price | 0.6221 |
| Market Cap | 17.67M |